, de Médecine Interne et Immunologie Clinique, F-59000 Lille, France. 4 Centre National de Référence Maladies Systémiques et Auto-immunes Rares

F. Lille, Health Care Provider of the European Reference Network on Rare Connective Tissue and Musculoskeletal Diseases Network (ReCONNET), F-59000

, Service d'Explorations Fonctionnelles Respiratoires, F-59000

E. Hachulla and D. Launay, Diagnosis and classification of systemic sclerosis, Clin Rev Allergy Immunol, vol.40, pp.78-83, 2011.

V. D. Steen and T. A. Medsger, Changes in causes of death in systemic sclerosis, Ann Rheum Dis, vol.66, pp.940-944, 1972.

E. Vandecasteele, D. Pauw, M. , D. Keyser, F. Decuman et al., Six-minute walk test in systemic sclerosis: a systematic review and meta-analysis, Int J Cardiol, vol.212, pp.265-73, 2016.

B. Balke, A simple field test for the assessment of physical fitness, Rep Civ Aeromed Res Inst US, vol.6, pp.1-8, 1963.

A. E. Holland, M. A. Spruit, T. Troosters, M. A. Puhan, V. Pepin et al., Technical Standard: field walking tests in chronic respiratory disease, Eur Respir J, vol.44, pp.1428-1474, 2014.

S. Miyamoto, N. Nagaya, T. Satoh, S. Kyotani, F. Sakamaki et al., Clinical correlates and prognostic significance of six-minute walk test in patients with primary pulmonary hypertension: comparison with cardiopulmonary exercise testing, Am J Respir Crit Care Med, vol.161, pp.487-92, 2000.

D. J. Lederer, S. M. Arcasoy, J. S. Wilt, D. 'ovidio, F. Sonett et al., Sixminute-walk distance predicts waiting list survival in idiopathic pulmonary fibrosis, Am J Respir Crit Care Med, vol.174, pp.659-64, 2006.

C. Casanova, C. G. Cote, J. M. Marin, J. P. De-torres, A. Aguirre-jaime et al., The 6-min walking distance: long-term follow up in patients with COPD, Eur Respir J, vol.29, pp.535-575, 2007.

A. J. Impens, S. Wangkaew, and J. R. Seibold, The 6-minute walk test in scleroderma-how measuring everything measures nothing, Rheumatol Oxf Engl, vol.47, issue.5, pp.68-77, 2008.

D. B. Badesch, V. F. Tapson, M. D. Mcgoon, B. H. Brundage, L. J. Rubin et al., Continuous intravenous epoprostenol for pulmonary hypertension due to the scleroderma spectrum of disease: a randomized, controlled trial, Ann Intern Med, vol.132, pp.425-459, 2000.

L. J. Rubin, D. B. Badesch, R. J. Barst, N. Galiè, C. M. Black et al., Bosentan therapy for pulmonary arterial hypertension, N Engl J Med, vol.346, pp.896-903, 2002.

R. J. Oudiz, R. J. Schilz, R. J. Barst, N. Galié, S. Rich et al., Treprostinil, a prostacyclin analogue, in pulmonary arterial hypertension associated with connective tissue disease, Chest, vol.126, pp.420-427, 2004.

K. Ahmadi-simab, B. Hellmich, and W. L. Gross, Bosentan for severe pulmonary arterial hypertension related to systemic sclerosis with interstitial lung disease, Eur J Clin Invest, vol.36, issue.3, pp.44-52, 2006.

J. R. Seibold, C. P. Denton, D. E. Furst, L. Guillevin, L. J. Rubin et al., Randomized, prospective, placebo-controlled trial of bosentan in interstitial lung disease secondary to systemic sclerosis, Arthritis Rheum, vol.62, pp.2101-2109, 2010.

M. H. Buch, C. P. Denton, D. E. Furst, L. Guillevin, L. J. Rubin et al., Submaximal exercise testing in the assessment of interstitial lung disease secondary to systemic sclerosis: reproducibility and correlations of the 6-min walk test, Ann Rheum Dis, vol.66, pp.169-73, 2007.

W. O. Villalba, P. D. Sampaio-barros, M. C. Pereira, E. M. Cerqueira, C. A. Leme et al., Six-minute walk test for the evaluation of pulmonary disease severity in scleroderma patients, Chest, vol.131, pp.217-239, 2007.

M. Ciurzy?ski, P. Bienias, B. Lichodziejewska, A. Szewczyk, M. Gli?ska-wielochowska et al., Assessment of left and right ventricular diastolic function in patients with systemic sclerosis, Kardiol Pol, vol.66, pp.277-285, 2008.

M. C. Garin, K. B. Highland, R. M. Silver, and C. Strange, Limitations to the 6-minute walk test in interstitial lung disease and pulmonary hypertension in scleroderma, J Rheumatol, vol.36, pp.330-336, 2009.

Y. Schoindre, C. Meune, A. T. Dinh-xuan, J. Avouac, A. Kahan et al., Lack of specificity of the 6-minute walk test as an outcome measure for patients with systemic sclerosis, J Rheumatol, vol.36, pp.1481-1486, 2009.

A. Akdogan, E. B. Kaya, A. Sahin, S. Okutucu, E. Yakut et al., Relationship between left ventricular diastolic dysfunction and six minute walk test in patients with systemic sclerosis, Int J Rheum Dis, vol.14, pp.379-83, 2011.

K. Deuschle, K. Weinert, M. O. Becker, M. Backhaus, D. Huscher et al., Six-minute walk distance as a marker for disability and complaints in patients with systemic sclerosis, Clin Exp Rheumatol, vol.29, pp.53-62, 2011.

M. Wilsher, N. Good, R. Hopkins, P. Young, D. Milne et al., The sixminute walk test using forehead oximetry is reliable in the assessment of scleroderma lung disease, Respirology, vol.17, pp.647-52, 2012.

L. Chung, H. Chen, D. Khanna, and V. D. Steen, Dyspnea assessment and pulmonary hypertension in patients with systemic sclerosis: utility of the University of California, Arthritis Care Res, vol.65, pp.454-63, 2013.

K. Irzyk, P. Bienias, M. Kostrubiec, Z. Rymarczyk, Z. Bartoszewicz et al., Six-minute walk test reflects neurohormonal activation and right ventricular function in systemic sclerosis patients, Clin Exp Rheumatol, vol.31, pp.18-23, 2013.

T. Lima, F. S. Guimarães, L. A. Silva, D. Silva, S. Menezes et al., Relationship between functional capacity, joint mobility and pulmonary function in patients with systemic sclerosis, J Bodyw Mov Ther, vol.19, pp.17-24, 2015.

T. Lima, F. S. Guimarães, M. N. Carvalho, T. Sousa, S. Menezes et al., Lower limb muscle strength is associated with functional performance and quality of life in patients with systemic sclerosis, Braz J Phys Ther, vol.19, pp.129-165, 2015.

M. Rizzi, P. Sarzi-puttini, A. Airoldi, M. Antivalle, M. Battellino et al., Performance capacity evaluated using the 6-minute walk test: 5-year results in patients with diffuse systemic sclerosis and initial interstitial lung disease, Clin Exp Rheumatol, vol.33, pp.142-149, 2015.

A. J. Lopes, S. Ferreira-ade, T. Lima, S. Menezes, and F. S. Guimarães, An explanatory model of functional exercise capacity in patients with systemic sclerosis: considerations for rehabilitation programs, J Phys Ther Sci, vol.28, pp.569-75, 2016.

K. Kusunose, H. Yamada, S. Nishio, Y. Hirata, H. Seno et al., Echocardiographic Predictors for Worsening of Six-Minute Walk Distances in Patients With Systemic Sclerosis (Scleroderma), Am J Cardiol, vol.120, pp.315-336, 2017.

E. Vandecasteele, K. Thevissen, K. Melsens, D. Keyser, F. et al., Six-minute walk test in or out in evaluation of systemic sclerosis patients?, Clin Exp Rheumatol, vol.35, issue.4, pp.122-129, 2017.

F. Van-den-hoogen, D. Khanna, J. Fransen, S. R. Johnson, M. Baron et al., 2013 classification criteria for systemic sclerosis: an American College of Rheumatology/European League Against Rheumatism collaborative initiative, Ann Rheum Dis, vol.72, pp.1747-55, 2013.

, ATS Committee on Proficiency Standards for Clinical Pulmonary Function Laboratories. ATS statement: guidelines for the six-minute walk test, Am J Respir Crit Care Med, vol.166, pp.111-118, 2002.

P. L. Enright and D. L. Sherill, Reference equations for the six-minute walk in healthy adults, Am J Respir Crit Care Med, vol.158, pp.1384-1391, 1998.

G. Valentini, A. D. Rossa, S. Bombardieri, W. Bencivelli, A. J. Silman et al., European multicentre study to define disease activity criteria for systemic sclerosis. II. Identification of disease activity variables and development of preliminary activity indexes, Ann Rheum Dis, vol.60, pp.592-600, 2001.

T. A. Medsger, S. Bombardieri, L. Czirjak, R. Scorza, A. D. Rossa et al., Assessment of disease severity and prognosis in systemic sclerosis, Clin Exp Rheumatol, vol.21, pp.42-48, 2003.

J. F. Fries, P. Spitz, R. G. Kraines, and H. R. Holman, Measurement of patient outcome in arthritis, Arthritis Rheum, vol.23, pp.137-182, 1980.

R. Development-core and . Team, R: A language and environment for statistical computing, 2008.

A. E. Holland, C. J. Hill, I. Glaspole, N. Goh, L. Dowman et al., Impaired chronotropic response to 6-min walk test and reduced survival in interstitial lung disease, Respir Med, vol.107, pp.1066-72, 2013.

S. Provencher, D. Chemla, P. Hervé, O. Sitbon, M. Humbert et al., Heart rate responses during the 6-minute walk test in pulmonary arterial hypertension, Eur Respir J, vol.27, pp.114-134, 2006.

M. S. Lauer, Heart rate response in stress testing: clinical implications, ACC Curr J Rev, vol.10, pp.16-25, 2001.

P. H. Brubaker and D. W. Kitzman, Chronotropic incompetence: causes, consequences, and management, Circulation, vol.123, pp.1010-1030, 2011.

T. N. Amaral, F. A. Peres, A. T. Lapa, J. F. Marques-neto, and S. Appenzeller, Neurologic involvement in scleroderma: a systematic review, Semin Arthritis Rheum, vol.43, pp.335-382, 2013.

P. Bienias, M. Ciurzy?ski, M. Gli?ska-wielochowska, A. Szewczyk, D. Korczak et al., Heart rate turbulence assessment in systemic sclerosis: the role for the detection of cardiac autonomic nervous system dysfunction, Rheumatol Oxf Engl, vol.49, pp.355-60, 2010.

F. Someya, N. Mugii, and S. Oohata, Factors relating to impaired stroke volume during the 6-minute walk test in patients with systemic sclerosis, Clin Exp Rheumatol, vol.34, pp.152-158, 2016.

L. Ingle, A. S. Rigby, S. Nabb, P. K. Jones, A. L. Clark et al., Clinical determinants of poor six-minute walk test performance in patients with left ventricular systolic dysfunction and no major structural heart disease, Eur J Heart Fail, vol.8, pp.321-326, 2006.

O. A. Minai, J. F. Santacruz, J. M. Alster, M. M. Budev, and K. Mccarthy, Impact of pulmonary hemodynamics on 6-min walk test in idiopathic pulmonary fibrosis, Respir Med, vol.106, pp.1613-1634, 2012.

N. S. Goh, R. K. Hoyles, C. P. Denton, D. M. Hansell, E. A. Renzoni et al., Short term pulmonary function trends are predictive of mortality in interstitial lung disease associated with systemic sclerosis: pulmonary function trends in SSc-ILD, Arthritis Rheumatol. Arthritis Rheumatol, vol.69, issue.8, pp.1670-1678, 2017.

L. Gouellec, N. Duhamel, A. Perez, T. Hachulla, A. Sobanski et al., Predictors of lung function test severity and outcome in systemic sclerosis-associated interstitial lung disease, PLoS One, vol.12, p.181692, 2017.
URL : https://hal.archives-ouvertes.fr/hal-02519638

S. Sanges, D. Launay, R. L. Rhee, O. Sitbon, É. Hachulla et al., A prospective study of the 6 min walk test as a surrogate marker for haemodynamics in two independent cohorts of treatment-naïve systemic sclerosis-associated pulmonary arterial hypertension, Ann Rheum Dis, vol.75, pp.1457-65, 2016.

S. Chow, J. E. Pope, and S. Mehta, Lack of correlation of the health assessment questionnaire disability index with lung parameters in systemic sclerosis associated pulmonary arterial hypertension, Clin Exp Rheumatol, vol.26, pp.1012-1019, 2008.

M. A. Spruit, M. L. Watkins, L. D. Edwards, J. Vestbo, P. Calverley et al., Determinants of poor 6-min walking distance in patients with COPD: the ECLIPSE cohort, Respir Med, vol.104, pp.849-57, 2010.

C. Muangchan, S. Harding, S. Khimdas, A. Bonner, . Canadian-scleroderma-research et al., Association of C-reactive protein with high disease activity in systemic sclerosis: results from the Canadian Scleroderma Research Group, Arthritis Care Res, vol.64, pp.1405-1419, 2012.

P. J. Clements, W. K. Wong, E. L. Hurwitz, D. E. Furst, M. Mayes et al., Correlates of the disability index of the health assessment questionnaire: a measure of functional impairment in systemic sclerosis, Arthritis Rheum, vol.42, pp.2372-80, 1999.